For inquiries regarding availability, import process, or cost of YEZTUGO (lenacapavir) Injection :<\/strong> NEWS\/UPDATES<\/p>\n India Pharma Network acts solely as a facilitator for YEZTUGO (lenacapavir) Injection access. IPN does not manufacture, sell, or promote medicines and does not provide medical advice. All imports are:<\/p>\n The prescribing physician remains solely responsible for dosage, therapy, and clinical decisions.<\/p>\n","protected":false},"excerpt":{"rendered":" YEZTUGO, a human immunodeficiency virus type 1 (HIV-1) capsid inhibitor, is indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35 kg who are at risk for HIV-1 acquisition. Individuals must have a negative HIV-1 test prior to initiating YEZTUGO<\/p>\n
\nIndia Pharma Network (IPN)<\/strong>\u00a0: Headquartered in\u00a0New Delhi<\/strong>, with branch offices in\u00a0Delhi, Gurugram, Mumbai, Bangalore, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur\u00a0<\/strong>and\u00a0Lucknow<\/strong>, IPN supports medicine imports across India on a\u00a0Named Patient Import Basis<\/strong>\u00a0and for\u00a0personal use only<\/strong>.\u00a0Mobile\/WhatsApp:<\/strong>\u00a0Mr. Tarun: +91 9891 296 838 | \u00a0Mr. Neeraj: +91 9811 747 774.\u00a0Email:<\/strong>\u00a0info@indianpharmanetwork.co.in<\/a><\/p>\n\n
Compliance & Disclaimer<\/h5>\n
\n
YEZTUGO (lenacapavir) \u2013 a human immunodeficiency virus type 1 (HIV-1) capsid inhibitor drug therapy in India.<\/h2>\n
\n\n
\n Brand Name:<\/strong><\/td>\n YEZTUGO<\/td>\n<\/tr>\n \n Generic Name:<\/strong><\/td>\n lenacapavir Injection<\/td>\n<\/tr>\n \n Strength:<\/strong><\/td>\n \u2022 Tablets: 300 mg of lenacapavir
\n\u2022 Injection: 463.5 mg\/1.5 mL (309 mg\/mL) of lenacapavir in single-dose vials<\/td>\n<\/tr>\n\n Manufacturer:<\/strong><\/td>\n Gilead Sciences, Inc.<\/td>\n<\/tr>\n \n Approved By:<\/strong><\/td>\n EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n